Watch out for long position in GenmabGenmab has reached an important area, which before in time have been a good time to start a long postion.
67DKK
4.35 BDKK
16.47 BDKK
63.62 M
About GENMAB AS DKK1
Sector
CEO
Jan G. J. van de Winkel
Headquarters
Copenhagen
Website
Employees (FY)
2.2 K
Founded
1998
ISIN
DK0010272202
FIGI
BBG000M2RVH4
Genmab A/S is an international biotechnology company, which engages in the development of human antibody therapeutics for the treatment of cancer and other diseases. Its product pipeline includes daratumumab, marketed as DARZALEX for the treatment of certain indications of multiple myeloma; teprotumumab-trbw marketed as TEPEZZA for the treatment of thyroid eye disease; and ofatumumab, marketed as Arzerra for the treatment of certain indications of chronic lymphocytic leukemia. The company was founded by Donald Lee Drakeman, Florian Schonharting, and Jan G. J. van de Winkel on June 11, 1998, and is headquartered in Copenhagen, Denmark.
Genmap Correction -40 %I like Genmab. The stock was one of my long positions for many years. I went into cash in the fall of 2021. After minus 40 percent, I will now gradually add to Genmab again.
Genmab is a era done ?I have sold all of my genmab shares i started to buy at the start of corona, 5 year tmeframe i think we see a head an shoulder formation an hoping to buy again 15-1600 kr :)
in the stockHello again, i bought this stock last year at like 1500 kr, but unf. i see a Head an should forming in think it will fall a little back, of course i hope im wrong an go up from here :) An not selling holding at least 5-20 years :)
Inverse Cup and handle on the weekly $GMABInverse Cup and handle on the weekly $GMAB
- Inverse Cup and handle on the weekly
- VPVR acting as resistance
- Waiting for a trigger
Interesting cup with handle developmentLooks like we have a cup with handle. Potential target 3600-3800
Genmab opportunitysteamloss in the Genmab stock will likely fuel a new rush.
1) the 2 previous times times RSI has been below 30, it has resulted in strong returns. Will it happen a 3rd time?
2) The current strongly rising RSI will like make sure that the price will move and stay above the short term downward trend
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Curated watchlists where 0MGB is featured.
Frequently Asked Questions
The current price of 0MGB is 1978 DKK — it has decreased by 2.08% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on LSIN exchange GENMAB AS DKK1 stocks are traded under the ticker 0MGB.
GENMAB AS DKK1 is going to release the next earnings report on May 2, 2024. Keep track of upcoming events with our Earnings Calendar.
0MGB stock is 3.78% volatile and has beta coefficient of 0.44. Check out the list of the most volatile stocks — is GENMAB AS DKK1 there?
0MGB earnings for the last quarter are 32.32 DKK per share, whereas the estimation was 22.87 DKK resulting in a 41.35% surprise. The estimated earnings for the next quarter are 21.52 DKK per share. See more details about GENMAB AS DKK1 earnings.
GENMAB AS DKK1 revenue for the last quarter amounts to 4.74 B DKK despite the estimated figure of 4.49 B DKK. In the next quarter revenue is expected to reach 4.61 B DKK.
Yes, you can track GENMAB AS DKK1 financials in yearly and quarterly reports right on TradingView.
0MGB stock has fallen by 4.50% compared to the previous week, the month change is a 3.81% fall, over the last year GENMAB AS DKK1 has showed a 29.24% decrease.
0MGB net income for the last quarter is 640.00 M DKK, while the quarter before that showed 2.13 B DKK of net income which accounts for −69.94% change. Track more GENMAB AS DKK1 financial stats to get the full picture.
Today GENMAB AS DKK1 has the market capitalization of 131.28 B, it has decreased by 1.36% over the last week.
No, 0MGB doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 0MGB shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GENMAB AS DKK1 stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 24, 2024, the company has 2.20 K employees. See our rating of the largest employees — is GENMAB AS DKK1 on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GENMAB AS DKK1 technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GENMAB AS DKK1 stock shows the sell signal. See more of GENMAB AS DKK1 technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on GENMAB AS DKK1 future price: according to them, 0MGB price has a max estimate of 3436.33 DKK and a min estimate of 1860.00 DKK. Read a more detailed GENMAB AS DKK1 forecast: see what analysts think of GENMAB AS DKK1 and suggest that you do with its stocks.